Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inhibits Gi/o class of G-proteins, which are common downstream effectors of many GPCRs. If GPR160 signals via Gi/o, its function can be modulated. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
Selective Gαs protein antagonist. If GPR160 activates Gαs proteins, NF449 can indirectly modulate its activity. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
Inhibits Gq class of G-proteins. If GPR160 signals via Gq, its function can be impacted by this inhibitor. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 GTPase inhibitor. Some GPCRs can activate small G-proteins like Cdc42. ML141 can impact GPR160 if it signals via Cdc42. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Intracellular calcium chelator. GPCRs that elevate intracellular calcium levels can have their signaling impacted by BAPTA-AM. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
Adenylyl cyclase inhibitor. If GPR160 signals via increasing cAMP levels, SQ22536 can modulate its function. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
PKA inhibitor. GPCRs elevating cAMP activate PKA. If GPR160 uses this signaling cascade, KT5720 can impact its activity. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Myosin light chain kinase inhibitor. GPCRs that influence cell motility via MLCK can have their signaling modulated by ML-7. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. Some GPCRs signal through the PI3K-AKT pathway, and LY294002 can modulate GPR160 if it uses this route. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that targets the MAPK/ERK pathway. GPCRs that activate MAPK/ERK can have their function impacted by PD98059. | ||||||